Recommended Antibiotic Treatment for Streptococcal Infections
Penicillin remains the treatment of choice for streptococcal pharyngitis due to its proven efficacy, safety, narrow spectrum, and low cost. 1
First-Line Treatment Options
For Patients Without Penicillin Allergy
Oral penicillin V or amoxicillin for 10 days is the standard treatment. 1
Penicillin V dosing:
Amoxicillin dosing (often preferred in children due to better taste):
Intramuscular benzathine penicillin G (for patients unlikely to complete oral therapy):
The 10-day duration is essential to achieve maximal pharyngeal eradication of Group A Streptococcus and prevent acute rheumatic fever. 1 Shortening the course by even a few days results in appreciable increases in treatment failure rates. 2
For Patients With Penicillin Allergy
The type of penicillin allergy determines which alternative antibiotic is safe to use. 2
Non-Immediate (Non-Anaphylactic) Penicillin Allergy
First-generation cephalosporins are the preferred first-line alternatives. 1, 2
- Cephalexin: 20 mg/kg per dose twice daily (maximum 500 mg per dose) for 10 days 1
- Cefadroxil: 30 mg/kg once daily (maximum 1 gram) for 10 days 1
These have strong, high-quality evidence supporting their efficacy with only 0.1% cross-reactivity risk in patients with non-severe, delayed penicillin reactions. 2
Immediate/Anaphylactic Penicillin Allergy
Avoid all beta-lactam antibiotics (including cephalosporins) due to up to 10% cross-reactivity risk. 1, 2 Immediate reactions include anaphylaxis, angioedema, respiratory distress, or urticaria occurring within 1 hour of penicillin administration. 2
Clindamycin is the preferred alternative for immediate penicillin allergy:
- 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days 1, 2
- Approximately 1% resistance rate among Group A Streptococcus in the United States 2
- Strong, moderate-quality evidence for efficacy 1
Macrolide alternatives (with resistance concerns):
- Azithromycin: 12 mg/kg once daily (maximum 500 mg) for 5 days 1, 2
- Clarithromycin: 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days 1
Macrolide resistance among Group A Streptococcus ranges from 5-8% in the United States, though this varies geographically and temporally. 1, 2 Azithromycin requires only 5 days due to its prolonged tissue half-life, unlike other antibiotics that require the full 10 days. 2
Necrotizing Fasciitis and Streptococcal Toxic Shock Syndrome
For severe Group A streptococcal infections (necrotizing fasciitis or toxic shock syndrome), use clindamycin PLUS penicillin. 1
- Clindamycin: 600-900 mg every 8 hours IV (adults) 1
- Penicillin: 2-4 million units every 4-6 hours IV (adults) 1
The rationale for clindamycin is based on in vitro studies demonstrating toxin suppression and modulation of cytokine production, with superior efficacy versus penicillin in animal studies. 1 Penicillin should be added because only 0.5% of macrolide-resistant Group A streptococci in the United States are also clindamycin resistant. 1
Chronic Streptococcal Carriers
Chronic carriers generally do not require treatment, as they are unlikely to spread infection or develop complications. 1, 2 However, if treatment is indicated (e.g., during outbreaks, family history of rheumatic fever), use:
- Clindamycin: 20-30 mg/kg per day in three doses (maximum 300 mg per dose) for 10 days 1
- Amoxicillin/clavulanate: 40 mg amoxicillin/kg per day in three doses (maximum 2,000 mg amoxicillin per day) for 10 days 1
These regimens have been shown to yield high rates of pharyngeal eradication of streptococci in chronic carriers. 1
Critical Pitfalls to Avoid
- Never shorten the antibiotic course below 10 days (except azithromycin's 5-day regimen) - this increases treatment failure rates and risk of acute rheumatic fever 1, 2
- Do not use cephalosporins in patients with immediate/anaphylactic penicillin reactions - up to 10% cross-reactivity risk 1, 2
- Do not prescribe azithromycin or clarithromycin without considering local resistance patterns - macrolide resistance varies geographically and can lead to treatment failure 1, 2
- Do not use sulfonamides or tetracyclines - higher resistance rates and frequent failure to eradicate even susceptible organisms 3
- Do not routinely perform post-treatment throat cultures in asymptomatic patients who have completed therapy 1